share_log

Form 144 | 奥洛兹美医疗(HALO.US)高管拟出售1万股股份，价值约38.49万美元

Form 144 | Halozyme Therapeutics(HALO.US) Officer Proposes to Sell 384.89K in Common Stocks

moomoo News ·  Apr 17 16:06

SEC FILLINGS DISCLOSED/ Apr 17, $Halozyme Therapeutics (HALO.US)$ Officer MICHAEL LABARRE intends to sell 10,000 shares of its common stock on Apr 17, with a total market value of approximately $384.89K.

MICHAEL LABARRE has reduced shareholding in $Halozyme Therapeutics (HALO.US)$ by 50,000 shares since Feb 27, 2024, with a total value of approximately $2.02 million.

1713384373138067713.png

Source: Announcement

What is Form 144?

Form 144: Notice of Proposed Sale of Securities is a document issued by the Securities and Exchange Commission (SEC). Individuals such as executive officers and affiliates of a US-listed company must submit this form to the SEC when they intend to sell more than 5,000 shares or units of that company's stock, or if the sale price adds up to more than $50,000 in any three-month period. This regulation is known as Rule 144, under the Securities Act of 1933.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment